J Biol Chem, Vol. 275, Issue 7, 4995-5002, February 18, 2000
A Pattern-recognition Protein for
-1,3-Glucan
THE BINDING DOMAIN AND THE cDNA CLONING OF
-1,3-GLUCAN
RECOGNITION PROTEIN FROM THE SILKWORM, BOMBYX MORI*
Masanori
Ochiai
and
Masaaki
Ashida
From the Institute of Low Temperature Science, Hokkaido University,
Sapporo 060-0819, Japan
 |
ABSTRACT |
The
-1,3-glucan recognition protein (
GRP)
has strong specific affinity for
-1,3-glucan, a component of the
fungal cell wall. Its interaction with
-1,3-glucan initiates the
activation of the prophenoloxidase cascade, which is an important
defense system in invertebrates of many species. We cloned the cDNA
of the
GRP of the silkworm Bombyx mori. The
GRP
mRNA transcript was constitutively expressed in the hemocytes, fat
body, and epithelial cells of the naive silkworm. At the same time, a
bacterial or yeast challenge was indicated to intensify the
transcription. Comparison of the deduced amino acid sequence with known
sequences revealed that the
GRP contained a region
(Thr264 to Pro386) displaying significant
similarity to the catalytic regions of bacterial
-1,3-glucanases and
much higher similarity to the glucanase-like regions of Gram-negative
bacteria-binding proteins found in the silkworm B. mori
and the mosquito Anopheles gambiae. The region (Thr264 to Pro386) of the
GRP, however, was
demonstrated not to have appreciable affinity for
-1,3-glucan. A
recombinant peptide corresponding to an N-terminal region
(Tyr1 to Ala102) of the
GRP bound strongly
to
-1,3-glucan. These results indicate that the binding domain of
the
GRP for
-1,3-glucan is located in the N-terminal region.
Glucanases and the current pattern-recognition proteins that contain a
glucanase-like region seem to have a common origin in their molecular evolution.
 |
INTRODUCTION |
The innate immune system is recognized to be important for
self-defense against invading micro-organisms, especially in
invertebrates, because they lack the adaptive immunity employing
clonally selected molecules for the recognition of non-selves. In
mammals, the importance of the innate immune system is now appreciated
even more than before because recent findings have revealed that it is
essential to make the adaptive immune responses active (1). Over the past several years, proteins belonging to the Rel family have been
demonstrated to work in intracellular signaling for the activation of
acute-phase protein genes in both mammals and insects (2). In the
extracellular signaling of the recognition of microbes as foreign,
insects and mammals have also been shown to employ homologues. Toll, a
receptor on the fat body (an organ equivalent to the vertebrate liver)
of Drosophila (3), and Toll-like receptor 2 on peripheral
blood leukocytes of humans (4) have been indicated to work in the
transduction of extracellular signals. The peptidoglycan recognition
protein (PGRP)1 is another
example where homologues have been demonstrated or suggested to take
part in the extracellular recognition of foreignness in the innate
immunity of both mammals and insects (5, 6). These common employments
of homologues in the intracellular and extracellular signaling
mechanisms indicate close links between innate immunity of mammals and insects.
A variety of bacterial and fungal cell wall components including
lipopolysaccharide, peptidoglycan, and
-1,3-glucan are collectively referred to as pathogen-associated molecular patterns (PAMPs) (7). They
are biologically active and elicit various innate immune reactions such
as septic shock, cytokine synthesis, and acute-phase protein synthesis
in both insects and mammals. In the innate immune mechanism, PAMPs are
recognized by particular pattern-recognition proteins, which could be
present on effector cell surfaces as receptors or as free-floating
molecules in the plasma fraction. In insects, any receptor for PAMP has
not been identified yet, but several of the free-floating
pattern-recognition proteins have been identified. They are the
-1,3-glucan recognition protein (
GRP) (8), PGRP (9),
lipopolysaccharide-binding protein (10, 11), Gram-negative
bacteria-binding protein (GNBP) (12), hemolin (13), and lectins with
varied specificities for saccharides (14-17). Physiological functions
of some pattern-recognition proteins are known. However, none of the
mechanisms used for binding to particular patterns have been elucidated.
The molecular mechanisms of the recognition of
-1,3-glucan as
foreign have not been studied in detail at present. Although the
receptors and recognition proteins have been indicated to be present in
mammals (18), they have not been isolated, and their molecular
identities remain to be studied. In invertebrates, no receptor for
-1,3-glucan has been demonstrated either, but proteins with affinity
for
-1,3-glucan have been isolated from the silkworm (8), crayfish
(19), earthworm (20), and horseshoe crab (21), and some of their
properties have been reported. All of these proteins have been reported
to participate in triggering the proteolytic cascade for melanin
formation or blood coagulation. However, their properties at the
molecular level are quite different, and the binding domains for
-1,3-glucan have not been identified.
Insect
GRP was originally identified as a component of the
prophenoloxidase cascade of the silkworm Bombyx mori (8).
The
GRP has been shown to have a strong specific affinity for
-1,3-glucan. Binding of the
GRP with
-1,3-glucan initiates the
activation of the prophenoloxidase cascade. The binding of PGRP with
peptidoglycan has also been shown to initiate the activation of the
cascade (9). Besides PGRP and
GRP, the cascade is composed of serine protease zymogens, prophenoloxidase, and components yet to be discovered (22). The cascade has often been thought to be an effector
mechanism only for the production of melanin around foreign objects
such as bacteria, fungi, and non-habitual endoparasites. However, it is
now speculated to be a signaling mechanism by which recognition signals
for fungi (
-1,3-glucan) and bacteria (peptidoglycan and
lipopolysaccharide) are relayed to effector cells.
Realizing the paucity of our understanding of the recognition
mechanisms of
-1,3-glucan as foreign in innate immunity of invertebrates and mammals, we conducted experiments on the silkworm
GRP with the following aims: to establish the identity of the silkworm
GRP and to identify the binding domain of
GRP for
-1,3-glucan.
We report here the cloning of
GRP cDNA from the cDNA library
of the hemocytes of the silkworm B. mori. The sequence
analysis showed that
GRP is a protein containing a glucanase-like
region in the central part and a glycosylphosphatidylinositol anchor attachment site in the hydrophobic C-terminal portion. The
glucanase-like region appears not to have affinity for
-1,3-glucan,
but the N-terminal fragment with 102 amino acids was shown to bind
strongly to the glucan.
 |
EXPERIMENTAL PROCEDURES |
Insects and Microorganisms--
Silkworms, B. mori
(strain Kinshu × Showa), were reared on an artificial diet as
described previously (23). In the experiments for immune challenge of
the insect, Enterobacter cloacae (JCM1232) and Candida
albicans (JCM2078) were used. C. albicans was grown in
a Potato-Dextrose broth medium (Difco) at 25 °C. At the late logarithmic phase of the growth, the cells were collected and suspended
in 10 mM bis-tris propane buffer, pH 6.5, containing 150 mM NaCl. The larvae on day 5 of the fifth instar were
injected with 10 µl of the suspension at A600 = 0.1. The bacterial challenge was carried out as described previously
(6).
Preparation of 20- and 43-kDa Fragments Derived from
GRP--
The
GRP was highly purified from the hemolymph of
silkworm larvae on day 5 of the fifth instar as described previously
(8). 400 µg of the protein was incubated with 1.0 µg of
-chymotrypsin (Sigma, TLCK-treated type VII from bovine pancreas) in
1.4 ml of 0.1 M Tris-HCl buffer, pH 8.5, at 37 °C for 30 min. This treatment caused a cleavage of
GRP into two fragments,
which migrated to positions of 20- and 43-kDa proteins in
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). After addition of 40 µl of 0.1 M phenylmethanesulfonyl fluoride in ethanol,
the reaction mixture was diluted 6 times with 20 mM
bis-tris propane buffer, pH 6.5, and immediately applied to a Mono Q
column HR5/5 (Amersham Pharmacia Biotech). The adsorbed
GRP-derived
20- and 43-kDa fragments were separated at a flow rate of 1 ml/min with
a liner gradient of NaCl from 50 to 250 mM in a total
volume of 20 ml of 10 mM bis-tris propane buffer, pH 6.5. The 20- and 43-kDa fragments were eluted at 200 and 120 mM
NaCl, respectively. Both the fragment solutions were individually dialyzed against 10 mM Tris maleate buffer, pH 6.5, containing 150 mM NaCl. The dialyzed solutions were
centrifuged at 16,000 × g for 10 min, and the
supernatants were used as the 20- and 43-kDa fragment solutions.
Protein Analysis--
SDS-PAGE was performed according to
Laemmli's method (24) in 12.5% separating gel under reducing
conditions. For the determination of the relative molecular mass in the
SDS-PAGE, marker proteins (Bio-Rad) were run with samples. Protein
concentrations were determined by the method of Lowry et al.
(25) with bovine serum albumin as a standard.
Preparation of Curdlan (Insoluble
-1,3-Glucan) Beads and
Curdlan Binding Assay--
Curdlan has a nature to form gel by
neutralization of its alkaline solution (26). The curdlan beads were
prepared as follows: 60 ml of 3% (w/v) curdlan in 0.1 N
NaOH solution was dropped at a flow rate of 60 ml/h into 240 ml of
1-butyl alcohol containing 0.5% (w/v) Tween 20 with vigorous stirring
to disperse the curdlan solution. The dispersed solution was dropped to
a mixture of 1-butyl alcohol (260 ml) and acetic acid (20 ml) with
stirring to neutralization. After gelation of the curdlan, the beads
were washed 5 times by decantation in 2 liters of distilled deionized
water. About 15 ml of the aqueous slurry of beads was obtained, and the
shape of the beads was spherical in diameters of 100-300 µm.
The curdlan binding assay was carried out by essentially the same
method as used before (8). Briefly, 50 µl of the curdlan beads
suspension was incubated with a sample solution (50-200 µl) for 10 min at room temperature. After the supernatant was removed by
centrifugation at 800 × g for 1 min, the beads were suspended in 0.5 ml of 10 mM bis-tris propane buffer, pH
6.5, containing 150 mM NaCl and centrifuged. The suspension
and centrifugation was repeated three times. Protein adsorbed to the
beads was eluted with 20 µl of SDS-PAGE solubilizing buffer (82 mM Tris-HCl buffer, pH 8.8, containing 1% SDS, 1%
-mercaptoethanol, 30% glycerol, and 0.01% bromphenol blue) at
boiling temperature for 5 min. The beads were removed by
centrifugation, and the supernatant was subjected to SDS-PAGE under
reducing conditions. Proteins were stained with Coomassie Brilliant
Blue and quantified densitometrically using the Analytical Imaging
Station software (Imaging Research Inc., Canada). It was confirmed that
at least 280 µg of the purified
GRP could bind the beads, and the
amount of the bound protein was quantitatively determined under the
experimental conditions.
Amino Acid Sequence Analysis and Mass Number Analysis--
For
the determination of N-terminal amino acid sequences of the
GRP, 20- and 43-kDa fragments, the preparations were desalted on a Wakopak
C4 column (4.6 × 150 mm, Wako Pure Chemical
Industries) in high performance liquid chromatography. The isolated
samples were analyzed by automated Edman degradation using a protein
sequencer PPSQ-10 (Shimadzu Corp.). For obtaining the internal
sequences of the 20- and 43-kDa fragments, the
S-pyridylethylated fragments were digested separately with
lysylendopeptidase (Wako Pure Chemical Industries) at a molar ratio of
enzyme to substrate of 1:100. Each digest was fractionated by
reversed-phase high performance liquid chromatography on a column of
STR ODS-II PEEK (4.6 × 150 mm, Shimadzu Corp.). The peptides
eluted as separated peaks were subjected to sequence analysis.
Mass number analyses were performed using a Kompact matrix-assisted
laser desorption and ionization (MALDI) mass spectrometer (model IV,
Shimadzu Corp.) in linear time of flight mode. A saturated sinapinic
acid in 0.1% (v/v) trifluoroacetic acid was used as a matrix. The
MALDI mass spectrometer was calibrated for the mass/H+
value using horse heart myoglobin (Mr 16,950.9)
and bovine serum albumin (Mr 66,525) as
standards before use.
Effect of 20- and 43-kDa Fragments on the Activation of the
Prophenoloxidase Cascade by
-1,3-Glucan--
The plasma
fraction of hemolymph was prepared according to the method of Ashida
(27). Mixtures of 5 µl of 100 µg/ml zymosan (a mixture of
-1,3-glucan and mannan) and 10 µl of 20- or 43-kDa fragment
solution at various concentrations were preincubated at 25 °C for 30 min. Each of the mixtures was added to a mixture of 83 µl of plasma
and 2 µl of 250 mM CaCl2, followed by
incubation at 25 °C. At intervals, phenoloxidase activity of the
mixtures at 25 °C was assayed spectrophotometrically as was
described previously (23). In a control experiment, 100 µg/ml
peptidoglycan from Micrococcus luteus was used instead of zymosan.
cDNA Cloning and Sequencing of
GRP--
Poly(A)+ RNA was extracted from the hemocytes
of silkworm larvae on day 5 of the fifth instar using a Quick Prep
Micro mRNA purification kit (Amersham Pharmacia Biotech). A
gt10
cDNA library was constructed from the poly(A)+ RNA
using a cDNA synthesis system and rapid cloning module (Amersham Pharmacia Biotech). The library was used as a template in the polymerase chain reaction (PCR). A pair of degenerate oligonucleotide primers was synthesized on the basis of the internal sequences, NEEMEG
and WFPTWD, respectively, of 20- and 43-kDa fragments: 5'-AAGAATTCAA(C/T)GA(A/G)GA(A/G)ATGGA(A/G)GG-3' and
5'- AAGAATTCTC(A/G)TCCCA(A/C/G/T)GT(A/C/G/T)GG(A/G)AACCA-3'. The PCR was repeated for 40 cycles with denaturation at 94 °C for 1 min, annealing at 60 °C for 2 min, and extension at 72 °C for 3 min. The product was digested with EcoRI, purified
with agarose gel electrophoresis, and labeled with
[
-32P]dCTP using a BcaBEST labeling kit (Takara Shuzo
Co.) to prepare a probe for
GRP cDNA. In screening the
gt10
hemocyte cDNA library, hybridization was carried out at 65 °C
for 16 h in 6× SSC (0.9 M NaCl, 90 mM
sodium citrate, pH 7.2), 5× Denhardt's solution (0.1%
polyvinylpyrrolidone, 0.1% bovine serum albumin and 0.1% Ficoll 400),
0.5% (w/v) SDS, and 100 µg/ml denatured salmon sperm DNA. The
membrane was washed twice in 2× SSC containing 0.5% (w/v) SDS at
65 °C for 15 min and subjected to autoradiography. The insert DNA of
the positive clones was subcloned into a BamHI site in the
pBluescript II SK vector (Stratagene) and sequenced by a DNA sequencer
(model 377, PE Applied Biosystems). The longest clone was used as the
GRP cDNA.
Determination of
-1,3-Glucanase Activity of
GRP--
A
mixture (pH 6.5) of 50 µl of 2 mg/ml laminarin, 40 µl of 1 mg/ml
GRP, and 10 µl of 50 mM CaCl2 was
incubated at 25 °C for 24 h. After the incubation, 5 µl of
the mixture was analyzed by thin layer chromatography on a silica gel
TLC aluminum sheet (Merck) using a mixture of n-propyl
alcohol/acetic acid/H2O (3:3:2, v/v) as a developing
solvent. The detection spray solution specific for reducing sugars was
10 mg/ml orcinol in 50% H2SO4. In a control experiment, Zymolyase-100T (Seikagaku Kogyo Co. LTD),
-1,3-glucan laminaripentaohydrolase from Arthrobacter luteus, was used
as an enzyme with
-1,3-glucanase activity.
Expression of the N-terminal Region of
GRP in Escherichia
coli--
To prepare various deletions in the N-terminal region of
GRP, cDNAs encoding the regions were amplified by PCR using the
GRP cDNA as a template. To add EcoRI and
SalI sites to the 5' and 3' ends, respectively, of the PCR
products, the primers were designed as follows:
5'-CGGAATTCTACGAGGCACCACCG-3' (
G1-F);
5'-CGGAATTCGCAATACACCCTAAAGG-3' (
G10-F);
5'-CGGAATTCGTTTCTGTTCCTGA-3' (
G18-F);
5'-CGGAATTCAACGAGGAAATGGAAGG-3' (
G35-F);
5'-CGGAATTCGGAGATAAGATTTACT-3' (
G70-F);
5'-ACGGTCGACTCAGAGCTTACCGTGAAACG-3' (
G34-R);
5'-ACGGTCGACTCAGATTTTCAGCGCTGCAT-3' (
G69-R);
5'-ACGGTCGACTCAGTATCCTAAGCCGTCCT-3' (
G86-R);
5'-ACGGTCGACTCATGTCCACTCCCCGTTAT-3' (
G94-R);
5'-ACGGTCGACTCATTCAACTGTCCACTCCCCGTTAT-3' (
G96-R);
5'-ACGGTCGACTCATACGAAACCTTCAACTG-3' (
G99-R);
ACGGTCGACTCAGGCTTCATCTACGAAAC-3' (
G102-R); and
ACGGTCGACTCATTCTACTCCTGGTGTTA-3' (
G119-R). The PCR products
were cleaved with EcoRI and SalI and cloned into the pET32a(+) vector (Novagen) which contains a sequence encoding the
thioredoxin (Trx), a His tag, and an enterokinase cleavage site. After
transformation of E. coli (strain, AD494(DE3) pLysS) by the
vectors, the cultures were grown at 37 °C. When
A600 of the cultures reached 0.4, the
expressions of the proteins coded by the vectors were induced by the
addition of isopropyl-
-D-thiogalactopyranoside to the
final concentration of 1.0 mM. The cells were incubated at
30 °C with shaking for 3 h and collected by centrifugation. The
cell pellets were suspended in 1/10 culture volume of 10 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl, lysed by
freezing and thawing, and centrifuged at 16,000 × g
for 10 min. The supernatants were recovered for the curdlan binding
assay and protein purification. The fusion proteins of Trx with the
N-terminal region of
GRP were purified with a His-Bind resin
according to the manufacturer's recommendations (Novagen). When the
peptide containing the Trx and spacer was removed from the fusion
proteins, the proteins were treated with enterokinase (Novagen) and
purified by Mono Q column chromatography.
Northern Blot Analysis--
Poly(A)+ RNA
preparations from hemocytes, fat body, epidermal cells, midgut, silk
gland, and Malpighian tubules of naive silkworms and total RNA from the
fat body of the bacteria- or yeast-challenged silkworms were prepared
as described previously (6). 2 µg of poly(A)+ RNA
preparations were run on 1% agarose gels, transferred to nylon
membranes (Hybond-N+, Amersham Pharmacia Biotech), and hybridized with
a 32P-labeled
GRP cDNA probe at 65 °C for 16 h in the hybridization solution as described above. The membranes were
washed twice with 2× SSC containing 0.5% SDS at 65 °C and
subjected to autoradiography. In the bacteria- or yeast-challenged
experiments, 30-µg aliquots of the total RNA preparations were
subjected to Northern blot analyses using cDNA probes of
GRP,
cecropin B (0.4 kbp), and
-tubulin (1.3 kbp) as described previously
(6).
 |
RESULTS |
20- and 43-kDa Fragments Derived from
GRP--
The silkworm
GRP is sensitive to
-chymotrypsin. Digestion by the protease gave
two major fragments. The mobilities of the fragments corresponded to
the positions of 20- and 43-kDa polypeptides in SDS-PAGE under reducing
conditions (Fig. 1A). These
fragments were purified on Mono Q column chromatography and subjected
to MALDI spectrometric analysis. The analysis revealed that the mass numbers of
GRP, the smaller, and larger polypeptides were 54,594, 13,338, and 41,313 Da, respectively (data not shown). The N-terminal sequences of these fragments and
GRP were analyzed as follows:
GRP, YEAPPATLEA; 20-kDa fragment, YEAPPATLEA; and 43-kDa fragment, TSTSLNPESP. These results indicate that
-chymotrypsin digested
GRP at a specific site under the experimental conditions and that
the 20-kDa fragment originated from the N-terminal of
GRP.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE (A) and curdlan
binding assay (B) of the 20- and 43-kDa fragments
derived from the silkworm GRP. Procedures
for the isolation of fragments and the binding assay are described
under "Experimental Procedures." Proteins were separated in 12.5%
polyacrylamide gel and stained with Coomassie Brilliant Blue. Samples
applied to each lane are as follows (the amounts of protein subjected
to SDS-PAGE (A) and the curdlan binding assay (B)
are indicated in parentheses): lane 1, purified GRP
(A, 3 µg; B, 6 µg); lane 2,
digestion of the GRP by -chymotrypsin (A, 3 µg;
B, 6 µg); lane 3, purified 43-kDa fragment
(A, 2 µg; B, 4 µg); lane 4,
purified 20-kDa fragment (A, 1 µg; B, 2 µg);
lane M, marker proteins.
|
|
For preliminary experiments to clarify the binding domain of
GRP to
-1,3-glucan, the digestions of
GRP with
-chymotrypsin were
subjected to the curdlan (insoluble
-1,3-glucan) binding assay. The
20-kDa fragment bound strongly to curdlan, but binding of the 43-kDa
fragment to curdlan could not be detected (Fig. 1B). The
purified 20-kDa fragment also bound to curdlan. Any appreciable difference in the affinity for curdlan was not detectable between the
20-kDa fragment and the purified
GRP. These results indicate that
the 20-kDa fragment originated from the N terminus of the
GRP and
has the binding domain for
-1,3-glucan.
Effects of 20- or 43-kDa fragments on the activation of the
prophenoloxidase cascade by
-1,3-glucan were investigated (Fig. 2). When
-1,3-glucan preincubated with
the purified 20-kDa fragment was added to the plasma fraction of the
silkworm, the
-1,3-glucan could not activate the cascade until at
least 100 min. On the other hand, peptidoglycan, another elicitor for
the cascade, triggered the activation of the cascade even if it had
been preincubated with the 20-kDa fragment.
-1,3-Glucan and
peptidoglycan preincubated with the 43-kDa fragment retained their
ability as elicitors for the cascade. These results suggest that the
20-kDa fragment bound to
-1,3-glucan prevented
GRP in the plasma
from interacting with the glucan, resulting in the deprivation of
elicitor activity of the preincubated
-1,3-glucan.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Activation of the prophenoloxidase cascade by
zymosan or peptidoglycan preincubated with the 20-kDa fragment
(A) and the 43-kDa fragment (B).
5 µl of 100 µg/ml of zymosan ( ), 100 µg/ml of peptidoglycan
( ), or H2O ( ) as a control was preincubated with 10 µl of 75 µg/ml 20-kDa fragment or 150 µg/ml 43-kDa fragment at
25 °C for 10 min. Each of the preincubated solutions was added to a
mixture of 2 µl of 250 mM CaCl2 and 83 µl
of silkworm plasma. The reaction mixtures were incubated at 25 °C,
and at intervals a 5-µl aliquot was assayed for phenoloxidase
activity to monitor the activation of the prophenoloxidase cascade. 20- and 43-kDa fragments, respectively, were used for the preincubation in
A and B.
|
|
Primary Structure of
GRP--
A pair of oligonucleotide primers
corresponding to the amino acid sequences of peptides derived from each
of the 20- and 43-kDa fragments was used in the PCR. The reaction
yielded a 1.3-kbp cDNA fragment that gave 1.0- and 0.3-kbp
fragments in the digestion with EcoRI. By using the 1.0-kbp
cDNA fragment as a probe for screening the cDNA library, 22 positive plaques were obtained. Among the cDNA clones in the
plaques, the longest three clones were sequenced. The complete sequence
of
GRP cDNA was determined and is shown in Fig.
3 with the deduced amino acid sequence.
This cDNA is composed of 1769 bp. An open reading frame of 1575 bp, nucleotides 123-1608, encoded a polypeptide consisting of 495 amino
acid residues. The first N-terminal amino acid of the purified
GRP
corresponded to the 17th amino acid from the beginning of the deduced
sequence. Thus, the mature protein consists of 479 residues, which give
rise to a polypeptide with a calculated molecular mass of 53,859.7 Da.
The amino acid sequence contains a putative N-glycosylation
site at the 362nd residue in the mature protein and a potential
sequence of glycosylphosphatidylinositol anchor attachment site
(Ala455- Arg 456-Ser457) (28) in
the C-terminal hydrophobic region. The predicted amino acid sequence
established here agrees well with the amino acid composition of the
purified
GRP reported in a previous report (8). The cleavage site by
-chymotrypsin was identified to be
Phe119-Thr120.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide sequence of cDNA encoding
GRP from B. mori and the deduced
amino acid sequence. The nucleotide sequence is numbered at
left (upper) and the amino acid sequence at
right (lower), beginning at the N terminus of the
mature protein. The underlined amino acid residues were
confirmed by sequencing of the peptides isolated after
lysylendopeptidase treatment of the S-pyridylethylated
GRP. The cleavage site of the mature protein by -chymotrypsin and
the putative N-linked glycosylation site are indicated by a
closed and an opened triangle, respectively. The
potential glycosylphosphatidylinositol anchor sequence is
boxed.
|
|
In the data base search,
GRP was revealed to show the highest
sequence similarity to the GNBP of the silkworm B. mori
(12). Both of the proteins have a glucanase-like domain of which the sequence is very similar to the catalytic domain of bacterial
-1,3-glucanases. Proteins with the glucanase-like domain were extracted from a data base. The sequences of the glucanase-like domains
are aligned in Fig. 4 together with the
putative catalytic domains of
-1,3-glucanases of bacteria (29-31)
and the sea urchin Strongylocentrotus purpuratus (32). Fig.
4 also includes the glucanase-like sequences from Drosophila
melanogaster found in the data base of the expressed sequence tag.
All glucanase-like domains in Fig. 4 have been located in the central
portion of the polypeptides except the one found in subunit
of
factor G from the horseshoe crab Tachypleus tridentatus
(33). The glucanase-like domain of the subunit
has been reported to
be in the N-terminal portion. The silkworm
GRP did not exhibit any
appreciable glucanase activity under the conditions described
under "Experimental Procedures."

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 4.
Sequence alignment of the
-1,3-glucanase-like region of the silkworm
GRP with the homologues. The sequence of the
silkworm B. mori GRP is from the present study. Other
sequences were found in the GenBankTM data base (release
110.0 1999) by BLASTA. The aligned sequences are from proteins as
follows (abbreviations used in this figure and accession numbers are
indicated in parentheses): silkworm B. mori GNBP (L38591)
(12); mosquito Anopheles gambiae GNBP (AJ001042) (42); fruit
fly D. melanogaster expression sequence tag (EST, AI109637);
earthworm E. foetida CCF-1 (AF030028) (20); horseshoe crab
T. tridentatus factor G subunit (FG- , D16622) (33);
sea urchin S. purpuratus -1,3-glucanase (S.p.
-Gase, U49711) (32); B. circulans -1,3-glucanase A1
(B.c. -Gase, M34503) (29); Clostridium
thermocellum -1,3(4)-glucanase (C.t. -Gase,
X89732) (30); and Thermotoga neapolitana -glucosidase
(T.n. -Gase, Z47974) (31). The alignments were done using
a CLUSTAL V program. Gaps indicated by hyphens
are introduced to optimized sequence alignment. Numbers on
the left and right indicate the residue numbers
of the amino acid sequence of each protein. Amino acid residues
identical to silkworm GRP are indicated by shaded boxes.
The catalytically active residues of B. licheniformis
-1,3-1,4-glucanase (40) are indicated by closed
triangles.
|
|
Expression of
GRP mRNA--
Northern blot analysis of
poly(A)+ RNA preparations from different tissues was
performed by using a
GRP cDNA probe. A 1.8-kb
GRP mRNA
transcript was detected in hemocytes, fat body, and epidermal cells but
not in Malpighian tubules, silk gland, and midgut of naive silkworm
(Fig. 5A). This result
indicates that the
GRP mRNA transcript is constitutively
expressed in the fat body and epidermal cells as major sites and in
hemocytes as a minor site. The inducibility of the
GRP mRNA
synthesis by the infection of microorganisms was investigated by
Northern blot analysis of total RNA from the fat body of
bacteria-injected and yeast-injected silkworms using the
GRP probe.
The amount of the
GRP mRNA transcript was shown to increase and
to remain at a high level from 6 to 24 h after injection of
bacteria (E. cloacae) and from 12 to 36 h after
injection of yeast (C. albicans) (Fig. 4B).
The same blot was dehybridized and re-hybridized with a cDNA probe
of cecropin B, an inducible anti-bacterial peptide, or
-tubulin, a
constitutively expressed protein. The cecropin B mRNA transcripts were confirmed to increase after injection of bacteria or yeast in a
kinetics paralleled to that observed in the expression of the
GRP
mRNA transcript. These results indicated that the expression of
GRP gene is inducible not only by a bacterial challenge but also by
a yeast challenge and that the
GRP is an acute-phase protein.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 5.
Northern blot analyses of tissue-specific
expression (A) and inducibility (B)
of GRP mRNA. A,
poly(A)+ RNA preparations were obtained from tissues of
silkworm larvae on day 5 of the fifth instar. 2 µg of
poly(A)+ RNA was loaded on each lane. Sources of the
poly(A)+ RNA preparations loaded to the lanes were as
follows: F, fat body; E, epidermal cells;
H, hemocytes; M, Malpighian tubules;
S, silk gland; and G, midgut. B,
silkworm larvae at the same developmental stage as in A were
challenged by E. cloacae or C. albicans as
described under "Experimental Procedures." Total RNA was extracted
from the fat body at the indicated times after the challenge. Total RNA
(30 µg) was subjected to Northern blot analysis where the blots were
hybridized separately with 32P-labeled cDNA probes of
silkworm GRP, cecropin B, and -tubulin. The names of the probes
and microorganisms for the challenge are indicated at the
left and top of the figure, respectively.
|
|
The Binding Domain of
GRP for
-1,3-Glucan--
In the
present study, the 20-kDa fragment covering the N-terminal region of
GRP was shown to bind to
-1,3-glucan (Fig. 1). To characterize
more specifically the
-1,3-glucan binding domain in this region, we
constructed 13 deletions of the N-terminal region of
GRP fused with
bacterial thioredoxin (Trx-
G), as shown in Fig.
6A. All the fusion proteins
were expressed as soluble proteins and subjected to a curdlan binding
assay. The results showed that Trx-
G1-34, 35-69, 70-119, 1-69,
35-119, 10-102, 18-102, 1-86, and 1-94 failed to bind
-1,3-glucan. However, the binding abilities of Trx-
G1-119, which
corresponds to the fusion protein of Trx with the entire amino acid
sequence of the 20-kDa fragment, and Trx-
G1-102 were not very much
different from the ability of the intact
GRP under the experimental
conditions. Trx-
G1-96 and 1-99 appeared to bind to
-1,3-glucan
with weaker affinities than the
GRP (Fig. 6B). To remove
the Trx and spacer peptide from the Trx-
G1-102, the fusion protein
was cleaved by enterokinase. The resulting peptide corresponding to
G1-102 was purified on Mono Q column chromatography. The purified
G1-102 had affinity for
-1,3-glucan. The
-1,3-glucan
preincubated with the purified recombinant peptide could not trigger
the activation of the prophenoloxidase cascade (data not shown) as in
the case of the 20-kDa fragment (Fig. 2). These results indicate that
the first 102 amino acid residues of
GRP constitute the
-1,3-glucan binding domain of
GRP.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 6.
The curdlan binding assay of fusion proteins
of Trx and deletions of GRP.
A, schematic diagram and summary of the deletions of GRP
for the binding experiments. These deletions were expressed in E. coli as fusion proteins with Trx. A rectangle on
top represents GRP and the amino acid residue numbers are
given below. The position of the peptide bond cleaved by
-chymotrypsin is indicated by a closed triangle. On the
left of the lower figure, amino acid residues at
the N-terminal and the C-terminal of each deletion are indicated by a
set of numbers that refer to amino acid residues of GRP as in Fig.
3. The location of deletions in the primary structure of 20-kDa
fragment is indicated by a bar. In the right
column, the results of the binding experiments of the fusion
proteins are summarized by using the following signs: +, binding; ±,
weak binding; , no binding. B, SDS-PAGE of the extracts of
E. coli expressing deletions and the results of curdlan
binding assay of the deletions. Methods for preparation of the extracts
from the transformed E. coli are described under
"Experimental Procedures." After the extracts were analyzed by
SDS-PAGE (left panel), the expressed fusion proteins in the
extracts were quantified densitometrically. The extracts (about 50-200
µl) containing 100 µg of the fusion protein that correspond to
about 2.5 nmol of the proteins and 2.5 nmol of the GRP were
subjected to curdlan binding assay. One-tenth of proteins eluted from
the curdlan beads was subjected to SDS-PAGE (middle panel).
The proteins bound to the beads were quantified by densitometry of the
stained gel, and their molar amounts were determined from the
calibration curves. The binding abilities of the fusion proteins are
given in the right panel as (moles of bound fusion
protein)/(moles of bound GRP) × 100. Samples applied to
lanes 1-5 originated from E. coli expressing
fusion proteins as follows: lane 1, Trx- G1-94;
lane 2, Trx- G1-96; lane 3, Trx- G1-99;
lane 4, Trx- G1-102; lane 5, Trx- G1-119.
M, marker proteins.
|
|
 |
DISCUSSION |
In the present study, cDNA of the silkworm
GRP was cloned.
The amino acid sequence that was deduced from the
GRP cDNA has a
putative signal sequence consisting of 16 amino acids and a mature
protein of 479 amino acid residues. The molecular masses calculated
from the deduced amino acid sequence and determined by MALDI mass
spectrometry of the purified
GRP were 53,859.7 and 54,571 Da,
respectively. This discrepancy may be due to the post-translational
modification of the nascent
GRP molecule. In fact, a potential
N-linked glycosylation site was identified at
Asn362, and the amino acid could not be detected by
automated Edman degradation. We previously reported that the
GRP
migrated to the position corresponding to 62 kDa in SDS-PAGE as shown
in Fig. 1 (8). It is probable that the silkworm
GRP behaved
anomalously in SDS-PAGE and migrated slower than the speed that was
expected from its molecular mass determined by MALDI spectrometry. A
similar anomalous behavior in SDS-PAGE was experienced with the 20-kDa fragment of the
GRP but not with the 43-kDa fragment, suggesting that the anomalous behavior of the
GRP may be assigned to the property of the 20-kDa fragment.
The deduced
GRP amino acid sequence does not have the sequence that
has often been observed with a transmembrane domain of receptors, but a
glycosylphosphatidylinositol anchor attachment site was detected in the
hydrophobic C-terminal region of the
GRP. Our previous report on the
immunocytochemical localization indicated that the
GRP was contained
not only in the plasma fraction but also in the granules of
granulocytes and in the spherules and on the surfaces of spherulocytes
of the silkworm B. mori (34). Western blot analysis of the
fat body and integument failed to detect the
GRP, but our recent
preliminary study on the immunolocalization indicated that the
GRP
is present also on the surfaces of the fat body
cells.2 These observations
seem to suggest that the
GRP is present both as free-floating
protein in the plasma and cell-bound form on the surface. The
cell-bound
GRP might cooperate with other proteins with a
transmembrane domain to transduce the signal for the recognition of
-1,3-glucan.
The prophenoloxidase cascade has also been reported in several
crustaceans and an earthworm species. Crayfish
-1,3-glucan-binding protein (
GBP) is reported to be a lipoprotein with dual functions working as a recognition protein for
-1,3-glucan and a lipid transfer protein (35). The crustacean
GBP has been shown to be
present in plasma. The complex of the crustacean
GBP and
-1,3-glucan was demonstrated to trigger a receptor-mediated
degranulation of hemocytes (36). The content of the
GBP in plasma
has been reported to be very high, about 0.1-0.4% of plasma protein
of the crayfish Pacifastacus leniusculus (19). Previously,
we developed a method to remove specifically
GRP from the plasma
fraction of the silkworm hemolymph of the fifth instar larvae, and we
named the fraction plasma-CPB (37). We have observed that
-1,3-glucan could not trigger prophenoloxidase cascade in the
plasma-CPB in which lipophorin is present. In insect hemolymph,
lipophorin is a plasma lipoprotein and functions as the lipid transfer
protein (38), and it is speculated to be an insect coagulogen (39). The
lipophorin seems to be the only major lipoprotein present in the
hemolymph of fifth instar silkworm larvae. Crayfish
GBP and silkworm
GRP are reported to be 100 and 62 kDa in SDS-PAGE, respectively, and
their other molecular properties are very different. Thus, it appears
to be certain that crayfish
GBP and silkworm
GRP are not
homologous proteins and that the silkworm
GRP is not a lipophorin or
lipoprotein. Coelomic cytolytic factor 1 (CCF-1) of the earthworm,
Eisenia foetida, was originally described to be responsible
for the cytolytic, opsonizing, and hemolytic properties of the coelomic
fluid. The CCF-1 has recently been reported to bind with
-1,3-
glucan and lipopolysaccharide (20). As the binding of the CCF-1 with
-1,3-glucan elicits the activation of the earthworm prophenoloxidase
cascade, the CCF-1 is considered to be functionally equivalent to the
silkworm
GRP in terms of activation of the cascade with
-1,3-glucan.
When the silkworm prophenoloxidase cascade is triggered by
-1,3-glucan or peptidoglycan, zymogens of serine protease are activated (23). To test the possibility that the
GRP is cleaved in
the process of the activation of the cascade, the cascade in plasma was
triggered with
-1,3-glucan and the change of molecular weight of the
GRP during the activation of the cascade was investigated by Western
blot analysis using a specific antibody against the
GRP. A change,
however, was not detected.3
The factor G of horseshoe crab initiates the activation of the blood
coagulation cascade when it binds to
-1,3-glucan. Factor G consists
of subunit
with affinity for
-1,3-glucan and subunit
with a
protease domain. The subunit
is degraded when factor G is incubated
with
-1,3-glucan, and its subunit
becomes enzymatically active
(21). Judging from the deduced amino acid sequence, it is almost clear
that silkworm
GRP itself is not a protease zymogen. This is
consistent with our previous observation that a complex of the purified
GRP with
-1,3-glucan did not hydrolyze any of the 26 peptidyl-7-amino-4-methylcoumarins, substrates for various proteases
(8). Furthermore, we examined the behavior of
GRP on gel-permeation
chromatography to get information of the possibility that
GRP is
present in non-covalent association with other proteins with a protease
domain in the plasma fraction of the silkworm hemolymph. In
chromatography of the plasma, the
GRP was eluted in a symmetrical
peak at the same retention time as the purified
GRP,3
indicating that the
GRP is not present as a non-covalently
associated form with other macromolecules. These observations indicate
that
GRP is different from factor G not only structurally but also may be different in the mode of its action. More thorough study on the
mechanism by which a complex of
GRP and
-1,3-glucan activates the
immediate downstream component of the prophenoloxidase cascade is
necessary. Such study would answer our question: what kind of activity
does the
GRP have when it binds to
-1,3-glucan?
To identify the domain responsible for the binding to
-1,3-glucan,
we prepared recombinant deletion fragments of the N-terminal region
(Tyr1 to Phe119) of the
GRP. By examining
the affinity of the deletions for
-1,3-glucan by the curdlan binding
assay, the sequence consisting of the N-terminal 10 residues and the
three residues from Asp100 to Ala102 were shown
to be important for the deletions to exhibit affinity for
-1,3-glucan (Fig. 6). The N-terminal region (20k-Da fragment) does
not contain a domain displaying similarity to the putative catalytic
domain of
-1,3-glucanase of microbial origin. Among the invertebrate
proteins having a glucanase-like domain in Fig. 4, the domains of the
GRP, GNBP, CCF-1, and factor G have been shown to be inactive
catalytically as
-1,3-glucanase. The
GRP and factor G have
specific binding affinity for
-1,3-glucan. The GNBP has been
reported to bind to Gram-negative bacteria but not to
-1,3-glucan,
and the CCF-1 binds to both
-1,3-glucan and lipopolysaccharide.
Glucanase-like domains of the GNBP and CCF-1 were speculated to be
binding sites for saccharide. The binding domain of factor G for
-1,3-glucan has been suggested to be three tandem repeats of a
xylanase A-like domain (33). However, unambiguous identification of the
binding domain for
-1,3-glucan of the invertebrate proteins with a
glucanase-like region was achieved in the present study for the first
time. With regard to a bacterial glucanase,
-1,3-1,4-glucanase from
Bacillus licheniformis, its catalytically active site has
been demonstrated to be present in the glucanase-like domain that is
homologous to those shown in Fig. 4. The glutamic acids and aspartic
acid in the sequence of
Glu-Ile-Asp-Ile-Glu, of which
location corresponds to Glu-Ile-Asp-Ile-Met-Glu in Fig. 4, were proved
to be essential or important for the enzymatic activity (40). With
another glucanase, Bacillus circulans
-1,3-glucanase A1
containing a glucanase domain, the binding domain for
-1,3-glucan
has been reported to be the N-terminal region that is different from
the glucanase domain (41). These observations indicate that the binding
domain and the catalytic domain of bacterial
-1,3-glucanases are
located separately in their primary structures. Therefore, it seems to be reasonable that the 43-kDa fragment containing a glucanase-like domain of
GRP was shown not to display appreciable affinity for
-1,3-glucan. The
-1,3-glucan binding region (Tyr1 to
Ala102) of
GRP shows only 26.5% identity and 40%
similarity to the corresponding N-terminal region of GNBP, whereas the
glucanase-like region (Thr264 -Pro386) of
GRP displayed 49.6% identity and 62.6% similarity to the glucanase-like region (Ser243-Ala372) of GNBP.
In light of this result, it is understandable that Lee et
al. (12) could not detect any apparent affinity of GNBP for
-1,3-glucan. The
-1,3-glucan binding region (Tyr1 to
Ala102) of the
GRP does not display significant
similarity to the xylanase A domain of factor G. Furthermore, in
sequences of factor G and CCF-1, we could not find a sequence
displaying significant similarity to the
-1,3-glucan binding region
(Tyr1 to Ala102) of
GRP. From these
observations, it seems reasonable to speculate that there exist more
than two kinds of domains with specific affinity for
-1,3-glucan
among invertebrate defense molecules that have affinity for
-1,3-glucan. Identification of the binding domain of factor G and
CCF-1 for
-1,3-glucan is awaited. Such knowledge together with our
present observations of the binding domain of
GRP would contribute
to advance our understanding of the phylogeny and functions of protein
domains with affinity for the
-1,3-glucan.
A feature of
GRP is that the synthesis is induced by a bacterial or
yeast challenge, although the gene is constitutively expressed. This
inducibility suggests that
GRP can be classified as an acute-phase
protein. We recently reported that the expression of the PGRP gene is
also induced by a bacterial or peptidoglycan challenge and that the
promoter region contains several cis-regulatory elements
such as cAMP response element, NF-
B-like element, and GATA motif
that have been found in both insect and mammalian acute-phase protein
genes. It is possible that the promoter region of the
GRP gene has
such cis-regulatory elements. We have observed before that
the prophenoloxidase cascade could not be triggered by
-1,3-glucan or peptidoglycan under the conditions where the recognition protein concentration is low (8, 9). It is probable that the concentration of
the recognition proteins decreases in vivo after insects are invaded by bacteria or fungi. Therefore, one possible physiological role of the inducibility of the
GRP and PGRP genes is to maintain the concentrations of the recognition proteins higher than a certain level in the hemolymph and to make the prophenoloxidase cascade constantly ready to be triggered by microbes with
-1,3-glucan or peptidoglycan.
It is well known that glucanase is distributed in bacteria, fungi, and
plants. Among Metazoa, only the sea urchin has been shown to have a
gene coding for
-1,3-glucanase. Bachman and McClay (32) argued for
the occurrence of the extremely ancient divergences of glucanases in
the prokaryotic/eukaryotic separation. Although it is not known why the
glucanase-like region without the catalytic activity is conserved in
some proteins of invertebrates, it seems to be probable that all these
proteins work as pattern-recognition proteins in their primary immune
responses to microbes and construct a family of glucanase-like
proteins. Our search of the current data base showed that a vertebrate
protein with sequence similarity to the glucanase-like region of
GRP
has not been deposited yet. It should be noted, however, that
homologues present both in insects and in mammals are currently being
found to be employed in their innate immune mechanisms. Considering
this and the fact that our studies on the mechanisms for the
recognition of
-1,3-glucan as foreign have not advanced in either
vertebrates or invertebrates, there seems to be a possibility that
recognition molecules homologous to the proteins with a glucanase-like
region will be found in vertebrates in the future.
 |
ACKNOWLEDGEMENT |
We are grateful to Dr. Y. Hayakawa in our
laboratory for technical advice.
 |
FOOTNOTES |
*
This work was supported in part by Research Grants 05740502, 09265201, and 09304075 from the Ministry of Education, Science, Sports
and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB026441.
To whom correspondence and reprint requests should be addressed:
The Institute of Low Temperature Science, Hokkaido University, Kita-ku
Sapporo 060-0819, Japan. Tel.: 81-11-706-6878; Fax: 81-11-706-7142; E-mail: ochiai@orange.lowtem.hokudai.ac.jp.
2
M. Ashida and M. Ochiai, unpublished observations.
3
M. Ochiai, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
PGRP, peptidoglycan
recognition protein;
PAMP, pathogen-associated molecular pattern;
GRP,
-1,3-glucan recognition protein;
GNBP, Gram-negative
bacteria-binding protein;
PAGE, polyacrylamide gel electrophoresis;
MALDI, matrix-assisted laser desorption and ionization;
PCR, polymerase
chain reaction;
Trx, thioredoxin;
Trx-
G, fusion protein of Trx and a
deletion of the N-terminal region of
GRP;
GBP,
-1,3-glucan
binding protein;
CCF-1, coelomic cytolytic factor 1;
bis-tris, 2-[bis(2-hydroxyethyl)- amino]-2-(hydroxymethyl)-propane-1,3-diol;
bp, base pair(s);
kbp, kilobase pair(s).
 |
REFERENCES |
| 1.
|
Medzhitov, R.,
and Janeway, C. A., Jr.
(1997)
Cell
91,
295-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Hultmark, D.
(1994)
Nature
367,
116-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Lemaitre, B.,
Nicolas, E.,
Michaut, L.,
Reichhart, J. M.,
and Hoffmann, J. A.
(1996)
Cell
86,
973-983[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Medzhitov, R.,
Preston-Hurlburt, P.,
and Janeway, C. A., Jr.
(1997)
Nature
388,
394-397[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kang, D.,
Liu, G.,
Lundström, A.,
Gelius, E.,
and Steiner, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10078-10082[Abstract/Free Full Text]
|
| 6.
|
Ochiai, M.,
and Ashida, A.
(1999)
J. Biol. Chem.
274,
11854-11858[Abstract/Free Full Text]
|
| 7.
|
Janeway, C. A., Jr.
(1989)
Cold Spring Harbor Symp. Quant. Biol.
54,
1-13
|
| 8.
|
Ochiai, M.,
and Ashida, M.
(1988)
J. Biol. Chem.
263,
12056-12062[Abstract/Free Full Text]
|
| 9.
|
Yoshida, H.,
Kinoshita, K.,
and Ashida, M.
(1996)
J. Biol. Chem.
271,
13854-13860[Abstract/Free Full Text]
|
| 10.
|
Jomori, T.,
and Natori, S.
(1991)
J. Biol. Chem.
266,
13318-13323[Abstract/Free Full Text]
|
| 11.
|
Koizumi, N.,
Morozumi, A.,
Imamura, M.,
Tanaka, E.,
Iwahana, H.,
and Sato, R.
(1997)
Eur. J. Biochem.
248,
217-224[Medline]
[Order article via Infotrieve]
|
| 12.
|
Lee, W. J.,
Lee, J. D.,
Kravchenko, V. V.,
Ulevitch, R. J.,
and Brey, P. T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7888-7893[Abstract/Free Full Text]
|
| 13.
|
Sun, S.,
Lindström, I.,
Boman, H.,
Faye, I.,
and Schmidt, O.
(1990)
Science
250,
1729-1732[Abstract/Free Full Text]
|
| 14.
|
Komano, H.,
and Natori, S.
(1985)
Dev. Comp. Immunol.
9,
31-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Pendland, J. C.,
and Boucias, D. G.
(1986)
Dev. Comp. Immunol.
10,
477-487[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Amanai, K.,
Sakurai, S.,
and Ohtaki, T.
(1990)
Comp. Biochem. Physiol.
97,
471-476[CrossRef]
|
| 17.
|
Kotani, E.,
Yamakawa, M.,
Iwamoto, S.,
Tashiro, M.,
Mori, H.,
Sumida, M.,
Matsubara, F.,
Taniai, K.,
Kadonookuda, K.,
Kato, Y.,
and Mori, H.
(1995)
Biochim. Biophys. Acta
1260,
245-258[Medline]
[Order article via Infotrieve]
|
| 18.
|
Wakshull, E.,
Brunke-Reese, D.,
Lindermuth, J.,
Fisette, L.,
Nathans, R. S.,
Crowley, J. J.,
Tufts, J. C.,
Zimmerman, J.,
Mackin, W.,
and Adams, D. S.
(1999)
Immunopharmacology
41,
89-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Duvic, B.,
and Söderhäll, K.
(1990)
J. Biol. Chem.
265,
9327-9332[Abstract/Free Full Text]
|
| 20.
|
Beschin, A.,
Bilej, M.,
Hanssens, F.,
Raymakers, J.,
Van Dyck, E.,
Revets, H.,
Brys, L.,
Gomez, J.,
De Baetselier, P.,
and Timmermans, M.
(1998)
J. Biol. Chem.
273,
24948-24954[Abstract/Free Full Text]
|
| 21.
|
Muta, T.,
Seki, N.,
Takaki, Y.,
Hashimoto, R.,
Oda, T.,
Iwanaga, A.,
Tokunaga, F.,
and Iwanaga, S.
(1995)
J. Biol. Chem.
270,
892-897[Abstract/Free Full Text]
|
| 22.
|
Ashida, M.,
and Brey, P. T.
(1997)
in
Molecular Mechanisms of Immune Responses in Insects
(Brey, P. T.
, and Hultmark, D., eds)
, pp. 135-172, Chapman and Hall, London
|
| 23.
|
Yoshida, H.,
and Ashida, M.
(1986)
Insect Biochem.
16,
539-545[CrossRef]
|
| 24.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25 |